May 7, 2012
Dr. LaForce Honored for his Integral Role in Developing a New Meningitis Vaccine
Washington, D.C. - May 7, 2012 – Today, the Sabin Vaccine Institute presented its annual Albert B. Sabin Gold Medal Award to Dr. F. Marc LaForce for his integral role in developing a new meningitis vaccine, MenAfriVac™, which has the potential to prevent one million cases of disease and save 150,000 lives and up to $300 million in medical costs over the next decade.
April 27, 2012
Washington, April 27, 2012 -- Health workers are walking, pedaling bicycles, driving cars, rowing boats and riding horses to reach remote areas, urban fringes and displaced communities, where they are giving vaccines against diseases like measles and polio as part of the first World Immunization Week taking place in 180 countries this week.
April 24, 2012
WASHINGTON, D.C., April 24, 2012—In a special edition of Vaccine released today, Sabin President, Dr. Peter Hotez, and Sabin Executive Vice President, Dr. Ciro de Quadros, share their insights on global health innovations and advancements since the eradication of smallpox was certified by the World Health Assembly in 1980. Their commentary is included in a special supplement that highlights discussions and research from the historic symposium “Smallpox Eradication after 30 Years: Lessons, Legacies and Innovations.”
April 5, 2012
Foreign Policy Association Global Health Blog
Meningococcal Meningitis: Q&A with Dr. Ciro de Quadros of the Sabin Vaccine Institute
By Julia Robinson
Meningococcal disease, or meningitis, is a bacterial infection of the meninges, or lining around the brain and spinal cord. If left untreated, it has a 50% mortality rate, and it spreads most easily through crowded areas where people are in close and prolonged contact, from college dorms to informal settlements. Meningococcal disease can result in severe, permanent conditions such as brain damage, hearing loss, and learning disability (WHO).
April 5, 2012
The Atlantic
Controlling the Typhoid Epidemic Plaguing Sub-Saharan Africa
By Chris Nelson, director of the Coalition against Typhoid (CaT)
The Coalition against Typhoid was established to combat this neglected disease and advocate for the millions currently suffering from it.
Since early November 2011, there has been a surge of typhoid fever outbreaks in central and southern Africa, affecting children and adults alike. Unfortunately, it takes a series of outbreaks such as these in Zambia, Zimbabwe, and the Democratic Republic of Congo (DRC), to draw attention to this often-overlooked disease in a region plagued by many needs and few resources.
Typhoid outbreaks usually occur when common water and food sources become contaminated with infected human waste. Symptoms include high fever, flu-like symptoms, abdominal pain, constipation or diarrhea, and even death. According to the World Health Organization (WHO) approximately 21.6 million cases of typhoid occur each year, resulting in at least 200,000 deaths, mostly among school- and preschool-aged children.
March 28, 2012
A New Clinic in Houston has been Established to Fight These Infections
Washington D.C., March 27, 2012— A paper jointly published in Public Library of Science (PLoS) called for increased attention to diseases that infect people living in poverty in Texas and Mexico. According to the authors of the paper, increased surveillance, improved education for healthcare workers and new therapies are necessary in order to control the high rates of neglected tropical diseases (NTDs) like Chagas disease, dengue fever, leishmaniasis and hookworm.
March 20, 2012
Globally, an estimated 1,000 women die every day from pregnancy and childbirth complications -- the majority of whom live in sub-Saharan Africa and South Asia. Both of these regions have a disproportionally high burden of diseases known as neglected tropical diseases (NTDs). While NTDs affect men, women, and children, one NTD in particular, hookworm, has devastating effects for pregnant women.
March 15, 2012
Buenos Aires, Argentina—March 15, 2012—Heath experts from throughout the Americas will reveal new findings on the meningitis disease prevalence in Latin America and Caribbean (LAC), following a March 19-20, 2012 regional health meeting. Researchers will present the first-ever study to estimate the cost of meningococcal disease in selected countries in the region, as well costs associated with control of an outbreak. These new findings will call attention to the need for improved meningococcal vaccination programs throughout the region.
February 28, 2012
We are pleased to announce that Sabin executive vice president, Ciro de Quadros, M.D., M.P.H., has been awarded the BBVA Frontiers of Knowledge Award in Development Cooperation, an international distinction of the highest level. Dr. de Quadros was honored for leading the efforts to eliminate measles and polio from the Western hemisphere and for being an important player in the eradication of smallpox worldwide.
Below is the press release from the BBVA Foundation.
February 24, 2012
The Lancet
A recent expert meeting on typhoid epidemiological modeling, organized by the Coalition against Typhoid, marks one of the first attempts to jolt governments into action against typhoid fever, a disease that is thriving largely unnoticed in many developing countries.
John Maurice reports on the issue in this month's edition of The Lancet. In the article he interviews Chris Nelson, director of the Coalition against Typhoid (CaT) secretariat at the Sabin Vaccine Institute, Jeremy Farrar, professor of tropical medicine and director of the Oxford University Clinical Research Unit in Vietnam, Zulfiqar Bhutta, founding chair of the Women and Child Health Division at the Aga Khan University in Karachi, Pakistan, and Seth Berkley, CEO of the GAVI Alliance.
February 17, 2012
Baroness Helene Hayman, Recent Lord Speaker of the House of Lords, United Kingdom Parliament, asks the UK government about its commitment to NTDs.
Below is an excerpt from the Baroness’ speech, which occurred on January 26, 2012:
View her speech.
View the meeting.
View the full transcript.
Asked By Baroness Hayman
To ask Her Majesty’s Government what international support they expect to receive for the new Department for International Development initiative to combat neglected tropical diseases announced on 21 January.
February 8, 2012
Press Release
NGOs, multilateral organizations, decision makers and global health experts will address Rubella elimination and CRS prevention in Europe
ROME, Italy—February 8, 2012—This week, the Sabin Vaccine Institute, together with the March of Dimes Foundation, the World Health Organization Regional Office for Europe (WHO/Europe), the International Pediatric Association and its regional affiliate, the European Pediatric Association and the United States Centers for Disease Control and Prevention (CDC), will bring together experts from around the world to discuss the continued outbreaks of measles and rubella in the European region. The meeting will also focus on the impact of associated congenital rubella syndrome (CRS) and the pressing need to increase regional measles and rubella vaccine coverage to ensure immunity among susceptible populations.
February 8, 2012
For the fifth year in a row, the Sabin Vaccine Institute has received Charity Navigator's highest rating, "for sound fiscal management and commitment to accountability and transparency." Charity Navigator is America's premier charity evaluator, providing donors with essential information needed to give them greater confidence in the charitable choices they make. Charity Navigator's review of Sabin can now be viewed on their website.

January 19, 2012
The Atlantic
A Military Cutback We Can't Afford: Fighting Tropical Diseases
By Peter Hotez and James Kazura
Jan 19 2012, 8:06 AM ET
As long as we have a military presence in areas known for infectious diseases, we have to keep researchers working on improved treatments.
In recent months, many politicians and presidential hopefuls have called for budget reductions, and many have specifically targeted military spending for cutbacks. Unfortunately, even programs proven to be cost effective are vulnerable to cuts. Medical research for our troops is no exception to this rule -- programs such as the Walter Reed Army Institute of Research (WRAIR) often find themselves low on the priority list despite their crucial role in saving the lives of our troops on the battlefield and here at home.